Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KusurinomadoguchiTSE:5592 +0.04%43 EV-to-EBIT is 10.44 as of Aug. 31, 2026, which is 0% below its 10-year median of 10.45. GuruFocus rates TSE:5592 with a GF Score™ of 43/100 and a GF Value™ of 円2,784.77 (Fairly Valued). The stock has 2 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Kusurinomadoguchi ranks better than 71.7% on this metric.
The historical rank and industry rank for Kusurinomadoguchi's EV-to-EBIT or its related term are showing as below:
TSE:5592'
s EV-to-EBIT Range Over the Past 10 Years
Min: 2.5 Med: 10.45 Max: 32.13
Current: 10.43
During the past 5 years, the highest EV-to-EBIT of Kusurinomadoguchi was 32.13. The lowest was 2.50. And the median was 10.45.
TSE:5592's EV-to-EBIT is ranked better than 71.7% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.73
vs TSE:5592: 10.43
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Kusurinomadoguchi's Enterprise Value for the quarter that ended in Mar. 2026 was 円25,689 Mil.
Kusurinomadoguchi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,775 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusurinomadoguchi EV-to-EBIT Related Terms
Kusurinomadoguchi EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Kusurinomadoguchi's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:5592 vs VEEV, BTSG, TEM: EV-to-EBIT Comparison
For the Health Information Services subindustry, Kusurinomadoguchi's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kusurinomadoguchi EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kusurinomadoguchi's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Kusurinomadoguchi's EV-to-EBIT falls into.
Kusurinomadoguchi's current Enterprise Value is 円28,960 Mil.
Kusurinomadoguchi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,775 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusurinomadoguchi (TSE:5592) has a EV-to-EBIT of 10.44 as of Aug. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Kusurinomadoguchi and its competitors. This is near median its historical median of 10.45. Over the past decade, Kusurinomadoguchi's EV-to-EBIT has ranged from 2.50 to 32.13. According to the industry distribution chart, Kusurinomadoguchi ranks #135 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 28.3%.
Is Kusurinomadoguchi's EV-to-EBIT too high?
Kusurinomadoguchi's current EV-to-EBIT of 10.44 is near median its 10-year median of 10.45. Over the past 10 years, this metric has ranged from a low of 2.50 to a high of 32.13. The Healthcare Providers & Services industry median EV-to-EBIT is 15.73. Kusurinomadoguchi's value of 10.44 is 33.6% below this industry median. Based on the distribution chart, Kusurinomadoguchi ranks #135 out of 477 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Kusurinomadoguchi has a GF Score™ of 43/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kusurinomadoguchi's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Kusurinomadoguchi ranks #135 out of 477 companies for EV-to-EBIT. This puts Kusurinomadoguchi in the upper half of its industry. The industry median EV-to-EBIT is 15.73. Kusurinomadoguchi's value of 10.44 is 33.6% below this benchmark. Historically, Kusurinomadoguchi's own EV-to-EBIT has ranged from 2.50 to 32.13 over the past decade. While the company's 10-year median is 10.45 vs. the industry median of 15.73, Kusurinomadoguchi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.73, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kusurinomadoguchi's current EV-to-EBIT of 10.44 is 33.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Kusurinomadoguchi and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kusurinomadoguchi's current EV-to-EBIT is 10.44, which is near median its own 10-year median of 10.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kusurinomadoguchi stock overvalued right now?
Based on GuruFocus' analysis, Kusurinomadoguchi (TSE:5592) is currently considered Fairly Valued. The stock's GF Value™ is 円2,784.77, compared to a current price of 円2,760.00 — trading 0.9% below its estimated fair value. The current EV-to-EBIT is 10.44, which is near median its 10-year median of 10.45 and 33.6% below the Healthcare Providers & Services industry median of 15.73. Kusurinomadoguchi's overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Kusurinomadoguchi (TSE:5592), the current EV-to-EBIT is 10.44 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kusurinomadoguchi (TSE:5592) Overvalued in 2026?
Based on GuruFocus' analysis, Kusurinomadoguchi stock appears to be undervalued.
The current stock price of 円2,760.00 is trading 0.9% below its estimated GF Value™ of 円2,784.77.
GuruFocus considers Kusurinomadoguchi to be Fairly Valued.
Key valuation signals for TSE:5592:
EV-to-EBIT: 10.44 (near median its 10-year median of 10.45)
GF Value™: 円2,784.77 vs. price of 円2,760.00 (0.9% below fair value)
Industry Position: 33.6% below the Healthcare Providers & Services median (#135 of 477)
No single metric tells the full story. See the TSE:5592 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kusurinomadoguchi Inc is engaged in providing solutions for pharmacies and medical facilities. The Group operates in a single segment and develops and sells medical solutions.
43GF Score
Get the complete analysis for TSE:5592
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5592 has been successfully added to your 
